These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 38968937)
1. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance. Yu J; Yan Y; Li S; Xu Y; Parolia A; Rizvi S; Wang W; Zhai Y; Xiao R; Li X; Liao P; Zhou J; Okla K; Lin H; Lin X; Grove S; Wei S; Vatan L; Hu J; Szumilo J; Kotarski J; Freeman ZT; Skala S; Wicha M; Cho KR; Chinnaiyan AM; Schon S; Wen F; Kryczek I; Wang S; Chen L; Zou W Cell; 2024 Aug; 187(17):4713-4732.e19. PubMed ID: 38968937 [TBL] [Abstract][Full Text] [Related]
2. Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer. Wescott EC; Sun X; Gonzalez-Ericsson P; Hanna A; Taylor BC; Sanchez V; Bronzini J; Opalenik SR; Sanders ME; Wulfkuhle J; Gallagher RI; Gomez H; Isaacs C; Bharti V; Wilson JT; Ballinger TJ; Santa-Maria CA; Shah PD; Dees EC; Lehmann BD; Abramson VG; Hirst GL; Brown Swigart L; van ˈt Veer LJ; Esserman LJ; Petricoin EF; Pietenpol JA; Balko JM Cancer Res Commun; 2024 Apr; 4(4):1120-1134. PubMed ID: 38687247 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway. Zhao Z; Zhang N; Li A; Zhou B; Chen Y; Chen S; Huang M; Wu F; Zhang L Cancer Lett; 2020 Aug; 485():14-26. PubMed ID: 32417396 [TBL] [Abstract][Full Text] [Related]
4. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells. Miao G; Sun X Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096 [TBL] [Abstract][Full Text] [Related]
5. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer. Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243 [TBL] [Abstract][Full Text] [Related]
6. B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas. Qi Y; Hu L; Ji C; Yang X; Yao J; Chen D; Yao Y Neoplasia; 2024 Aug; 54():101007. PubMed ID: 38796932 [TBL] [Abstract][Full Text] [Related]
7. Associations of B7-H3 and B7-H4 Expression in Ductal Carcinoma In Situ of the Breast With Clinicopathologic Features and T-Cell Infiltration. Kim NI; Park MH; Lee JS Appl Immunohistochem Mol Morphol; 2020; 28(10):767-775. PubMed ID: 31714284 [TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7-H4 in lung adenocarcinoma harboring EGFR-activating mutants. Lu Y; Sun Y; Zhang J; Kong M; Zhao Z; Sun B; Wang Y; Jiang Y; Chen S; Wang C; Tong Y; Wen L; Huang M; Wu F; Zhang L Cancer Lett; 2024 Aug; 596():217020. PubMed ID: 38849009 [TBL] [Abstract][Full Text] [Related]
9. B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression. Lu Y; Wu F; Cao Q; Sun Y; Huang M; Xiao J; Zhou B; Zhang L Oncogene; 2022 Jan; 41(5):704-717. PubMed ID: 34839353 [TBL] [Abstract][Full Text] [Related]
10. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration. Kim GE; Kim NI; Park MH; Lee JS Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model. Leung J; St-Onge P; Stagg J; Suh WK Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226 [TBL] [Abstract][Full Text] [Related]
12. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration. Kim NI; Park MH; Kweon SS; Lee JS Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722 [TBL] [Abstract][Full Text] [Related]
13. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer. Yuan L; Ye J; Fan D Hum Immunol; 2020 May; 81(5):254-261. PubMed ID: 32113654 [TBL] [Abstract][Full Text] [Related]
14. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape. Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530 [TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma. Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers. Song X; Zhou Z; Li H; Xue Y; Lu X; Bahar I; Kepp O; Hung MC; Kroemer G; Wan Y Cancer Discov; 2020 Dec; 10(12):1872-1893. PubMed ID: 32938586 [TBL] [Abstract][Full Text] [Related]
17. B7-H4 reduction induced by Toxoplasma gondii infection results in dysfunction of decidual dendritic cells by regulating the JAK2/STAT3 pathway. Sun X; Xie H; Zhang H; Li Z; Qi H; Yang C; Liu X; Ren L; Jiang Y; Hu X Parasit Vectors; 2022 May; 15(1):157. PubMed ID: 35505420 [TBL] [Abstract][Full Text] [Related]
18. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses. Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540 [TBL] [Abstract][Full Text] [Related]
19. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer. El Din GS; Youness RA; Assal RA; Gad MZ Microrna; 2020; 9(5):346-353. PubMed ID: 33297930 [TBL] [Abstract][Full Text] [Related]
20. Potential targeting of B7-H4 for the treatment of cancer. Podojil JR; Miller SD Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]